List of Tables
Table 1. Global Gene Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Major Companies of Viral Gene Therapy
Table 3. Major Companies of Non-Viral Gene Therapy
Table 4. Global Gene Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Gene Therapy Market Size by Region (US$ Million): 2023 VS 2030
Table 6. Global Gene Therapy Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Gene Therapy Revenue Forecast by Region (2025-2030) & (US$ Million)
Table 8. Gene Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 9. Gene Therapy Revenue Share by Company (2019-2024)
Table 10. Ranking of Global Top Gene Therapy Players by Revenue (US$ Million) in 2023
Table 11. Global Gene Therapy Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024)
Table 12. Global Gene Therapy by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapy as of 2023)
Table 13. Global Gene Therapy Companies Headquarters
Table 14. Global Gene Therapy Companies Product & Service
Table 15. Date of International Companies Enter into Gene Therapy Market
Table 16. Global Gene Therapy Mergers & Acquisitions, Expansion Plans
Table 17. Biogen Company Information
Table 18. Biogen Description and Business Overview
Table 19. Biogen Gene Therapy Product
Table 20. Biogen Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 21. Biogen Revenue Proportion of Gene Therapy by Product in 2023
Table 22. Biogen Revenue Proportion of Gene Therapy by Application in 2023
Table 23. Biogen Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 24. Biogen Recent Development
Table 25. Novartis Company Information
Table 26. Novartis Description and Business Overview
Table 27. Novartis Gene Therapy Product
Table 28. Novartis Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 29. Novartis Revenue Proportion of Gene Therapy by Product in 2023
Table 30. Novartis Revenue Proportion of Gene Therapy by Application in 2023
Table 31. Novartis Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 32. Novartis Recent Development
Table 33. Gilead Sciences Company Information
Table 34. Gilead Sciences Description and Business Overview
Table 35. Gilead Sciences Gene Therapy Product
Table 36. Gilead Sciences Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 37. Gilead Sciences Revenue Proportion of Gene Therapy by Product in 2023
Table 38. Gilead Sciences Revenue Proportion of Gene Therapy by Application in 2023
Table 39. Gilead Sciences Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 40. Gilead Sciences Recent Development
Table 41. Sarepta Therapeutics Company Information
Table 42. Sarepta Therapeutics Description and Business Overview
Table 43. Sarepta Therapeutics Gene Therapy Product
Table 44. Sarepta Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 45. Sarepta Therapeutics Revenue Proportion of Gene Therapy by Product in 2023
Table 46. Sarepta Therapeutics Revenue Proportion of Gene Therapy by Application in 2023
Table 47. Sarepta Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 48. Sarepta Therapeutics Recent Development
Table 49. Alnylam Pharmaceuticals Company Information
Table 50. Alnylam Pharmaceuticals Description and Business Overview
Table 51. Alnylam Pharmaceuticals Gene Therapy Product
Table 52. Alnylam Pharmaceuticals Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 53. Alnylam Pharmaceuticals Revenue Proportion of Gene Therapy by Product in 2023
Table 54. Alnylam Pharmaceuticals Revenue Proportion of Gene Therapy by Application in 2023
Table 55. Alnylam Pharmaceuticals Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 56. Alnylam Pharmaceuticals Recent Development
Table 57. Amgen Company Information
Table 58. Amgen Description and Business Overview
Table 59. Amgen Gene Therapy Product
Table 60. Amgen Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 61. Amgen Revenue Proportion of Gene Therapy by Product in 2023
Table 62. Amgen Revenue Proportion of Gene Therapy by Application in 2023
Table 63. Amgen Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 64. Amgen Recent Development
Table 65. Spark Therapeutics Company Information
Table 66. Spark Therapeutics Description and Business Overview
Table 67. Spark Therapeutics Gene Therapy Product
Table 68. Spark Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 69. Spark Therapeutics Revenue Proportion of Gene Therapy by Product in 2023
Table 70. Spark Therapeutics Revenue Proportion of Gene Therapy by Application in 2023
Table 71. Spark Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 72. Spark Therapeutics Recent Development
Table 73. Akcea Therapeutics Company Information
Table 74. Akcea Therapeutics Description and Business Overview
Table 75. Akcea Therapeutics Gene Therapy Product
Table 76. Akcea Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 77. Akcea Therapeutics Revenue Proportion of Gene Therapy by Product in 2023
Table 78. Akcea Therapeutics Revenue Proportion of Gene Therapy by Application in 2023
Table 79. Akcea Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 80. Akcea Therapeutics Recent Development
Table 81. bluebird bio Company Information
Table 82. bluebird bio Description and Business Overview
Table 83. bluebird bio Gene Therapy Product
Table 84. bluebird bio Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 85. bluebird bio Revenue Proportion of Gene Therapy by Product in 2023
Table 86. bluebird bio Revenue Proportion of Gene Therapy by Application in 2023
Table 87. bluebird bio Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 88. bluebird bio Recent Development
Table 89. Sunway Biotech Company Information
Table 90. Sunway Biotech Description and Business Overview
Table 91. Sunway Biotech Gene Therapy Product
Table 92. Sunway Biotech Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 93. Sunway Biotech Revenue Proportion of Gene Therapy by Product in 2023
Table 94. Sunway Biotech Revenue Proportion of Gene Therapy by Application in 2023
Table 95. Sunway Biotech Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 96. Sunway Biotech Recent Development
Table 97. SIBIONO Company Information
Table 98. SIBIONO Description and Business Overview
Table 99. SIBIONO Gene Therapy Product
Table 100. SIBIONO Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 101. SIBIONO Revenue Proportion of Gene Therapy by Product in 2023
Table 102. SIBIONO Revenue Proportion of Gene Therapy by Application in 2023
Table 103. SIBIONO Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 104. SIBIONO Recent Development
Table 105. AnGes Company Information
Table 106. AnGes Description and Business Overview
Table 107. AnGes Gene Therapy Product
Table 108. AnGes Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 109. AnGes Revenue Proportion of Gene Therapy by Product in 2023
Table 110. AnGes Revenue Proportion of Gene Therapy by Application in 2023
Table 111. AnGes Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 112. AnGes Recent Development
Table 113. Orchard Therapeutics Company Information
Table 114. Orchard Therapeutics Description and Business Overview
Table 115. Orchard Therapeutics Gene Therapy Product
Table 116. Orchard Therapeutics Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 117. Orchard Therapeutics Revenue Proportion of Gene Therapy by Product in 2023
Table 118. Orchard Therapeutics Revenue Proportion of Gene Therapy by Application in 2023
Table 119. Orchard Therapeutics Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 120. Orchard Therapeutics Recent Development
Table 121. Human Stem Cells Institute Company Information
Table 122. Human Stem Cells Institute Description and Business Overview
Table 123. Human Stem Cells Institute Gene Therapy Product
Table 124. Human Stem Cells Institute Gene Therapy Revenue (US$ Million) and Gross Margin (2019-2024)
Table 125. Human Stem Cells Institute Revenue Proportion of Gene Therapy by Product in 2023
Table 126. Human Stem Cells Institute Revenue Proportion of Gene Therapy by Application in 2023
Table 127. Human Stem Cells Institute Revenue Proportion of Gene Therapy by Geographic Area in 2023
Table 128. Human Stem Cells Institute Recent Development
Table 129. Global Gene Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 130. Global Gene Therapy Revenue Forecast by Type (2025-2030) & (US$ Million)
Table 131. Global Gene Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 132. Global Gene Therapy Revenue Forecast by Application (2025-2030) & (US$ Million)
Table 133. North America Gene Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 134. North America Gene Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 135. North America Gene Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 136. North America Gene Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 137. Asia-Pacific Gene Therapy Revenue by Region (2019-2030) & (US$ Million)
Table 138. Asia-Pacific Gene Therapy Revenue by Region (2025-2030) & (US$ Million)
Table 139. Asia-Pacific Gene Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 140. Asia-Pacific Gene Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 141. Europe Gene Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 142. Europe Gene Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 143. Europe Gene Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 144. Europe Gene Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 145. Latin America Gene Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 146. Latin America Gene Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 147. Latin America Gene Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 148. Latin America Gene Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 149. Middle East and Africa Gene Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 150. Middle East and Africa Gene Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 151. Middle East and Africa Gene Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 152. Middle East and Africa Gene Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 153. Gene Therapy Key Raw Materials, Industry Status and Trend
Table 154. Gene Therapy Key Raw Materials and Upstream Suppliers
Table 155. Gene Therapy Clients Status and Trend
Table 156. Gene Therapy Typical Clients
Table 157. Gene Therapy Distributors
Table 158. Gene Therapy Market Trends
Table 159. Gene Therapy Market Drivers
Table 160. Gene Therapy Market Challenges
Table 161. Gene Therapy Market Restraints
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapy Product Picture
Figure 2. Global Gene Therapy Revenue Market Share by Type in 2023 & 2030
Figure 3. Viral Gene Therapy Product Picture
Figure 4. Non-Viral Gene Therapy Product Picture
Figure 5. Global Gene Therapy Revenue Market Share by Application in 2023 & 2030
Figure 6. Neurological Diseases
Figure 7. Cancer
Figure 8. Other
Figure 9. Gene Therapy Report Years Considered
Figure 10. Global Gene Therapy Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Gene Therapy Market Size 2019-2030 (US$ Million)
Figure 12. Global Gene Therapy Market Size Market Share by Region: 2023 Versus 2030
Figure 13. Global Gene Therapy Revenue Market Share by Region (2019-2030)
Figure 14. Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 15. Global Gene Therapy Revenue Market Share Forecast by Type (2019-2030)
Figure 16. Global Gene Therapy Revenue Market Share Forecast by Application (2019-2030)
Figure 17. North America Gene Therapy Revenue 2019-2030 (US$ Million)
Figure 18. North America Gene Therapy Revenue Market Share by Type (2019-2024)
Figure 19. North America Gene Therapy Revenue Market Share by Application (2019-2024)
Figure 20. Asia-Pacific Gene Therapy Revenue 2019-2030 (US$ Million)
Figure 21. Asia-Pacific Gene Therapy Revenue Market Share by Region (2019-2030)
Figure 22. Asia-Pacific Gene Therapy Revenue Market Share by Type (2019-2024)
Figure 23. Asia-Pacific Gene Therapy Revenue Market Share by Application (2019-2024)
Figure 24. Europe Gene Therapy Revenue Growth Rate 2019-2030 (US$ Million)
Figure 25. Europe Gene Therapy Revenue Market Share by Country (2019-2030)
Figure 26. Europe Gene Therapy Revenue Market Share by Type (2019-2024)
Figure 27. Europe Gene Therapy Revenue Market Share by Application (2019-2024)
Figure 28. Latin America Gene Therapy Revenue Growth Rate 2019-2030 (US$ Million)
Figure 29. Latin America Gene Therapy Revenue Market Share by Country (2019-2024)
Figure 30. Latin America Gene Therapy Revenue Market Share by Type (2019-2024)
Figure 31. Latin America Gene Therapy Revenue Market Share by Application (2019-2024)
Figure 32. Middle East and Africa Gene Therapy Revenue Growth Rate 2019-2030 (US$ Million)
Figure 33. Middle East and Africa Gene Therapy Revenue Market Share by Country (2019-2030)
Figure 34. Middle East and Africa Gene Therapy Revenue Market Share by Type (2019-2024)
Figure 35. Middle East and Africa Gene Therapy Revenue Market Share by Application (2019-2024)
Figure 36. Gene Therapy Supply Chain (Upstream and Downstream Market)
Figure 37. Global Production Market Share of Gene Therapy Raw Materials by Region in 2023
Figure 38. Gene Therapy Distribution Channels
Figure 39. Global Gene Therapy Percentage 2019-2030: Indirect Sales VS Direct Sales
Figure 40. Global Gene Therapy Percentage 2019-2030: Online Sales VS Offline Sales
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Figure 44. Global Gene Therapy Percentage 2019-2030: Online Sales VS Offline Sales
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
